NewsBenzingaGuggenheim mantiene su recomendación de compra sobre CG Oncology y eleva su precio objetivo a 120 dólares Guggenheim mantiene su recomendación de compra sobre CG Oncology y eleva su precio objetivo a 120 dólares Benzinga 2026.11.19 14:30 (GMT+0) Open on Benzinga Other news Stifel Maintains Hold on Target, Raises Price Target to $160 Stifel Maintains Buy on BellRing Brands, Raises Price Target to $18 Tsakos Energy Navigation Q3 Adj. EPS $3.71 Beats $3.57 Estimate, Sales $299.610M Beat $211.672M Estimate Guggenheim Reiterates Buy on TJX Companies, Maintains $152 Price Target Walmart's Weight-Loss Drug Windfall Is Losing Steam $1000 Invested In Charles Schwab 15 Years Ago Would Be Worth This Much Today
Tsakos Energy Navigation Q3 Adj. EPS $3.71 Beats $3.57 Estimate, Sales $299.610M Beat $211.672M Estimate